TY - JOUR
T1 - Effect of varying definitions of hypopnea on the diagnosis and clinical outcomes of sleep-disordered breathing
T2 - A systematic review and meta-analysis
AU - Mansukhani, Meghna P.
AU - Kolla, Bhanu Prakash
AU - Wang, Zhen
AU - Morgenthaler, Timothy I.
N1 - Publisher Copyright:
© 2019 American Academy of Sleep Medicine. All rights reserved.
PY - 2019
Y1 - 2019
N2 - Study Objectives: Various criteria have been used for scoring hypopneas, leading to difficulties when comparing results in clinical and research settings. We conducted a systematic review and meta-analysis to assess the effect of different hypopnea definitions on the diagnosis, severity, and clinical implications of sleep-disordered breathing (SDB). Methods: Ovid MEDLINE, Embase, and Scopus databases were queried for English-language publications from inception through March 7, 2017. Studies that directly compared various hypopnea definitions were eligible. The hierarchical summary receiver operating characteristic model was used to jointly estimate diagnostic performance for comparisons between criteria. Results: The initial search yielded 2,828 abstracts; 28 met inclusion criteria. After reviewing reference lists and expert review, five additional articles were identified. Most of the studies were cross-sectional or retrospective in nature. Eleven studies compared 2007 recommended criteria with 2012 criteria; 6 of these (evaluating 6,628 patients) were suitable for inclusion in the meta-analysis. Using the 2012 definition (≥ 3% desaturation or arousal) as the reference standard, the 2007 definition (≥ 4% desaturation) showed a sensitivity of 82.7% (95% confidence interval 0.72–0.90) and specificity of 93.2% (95% confidence interval 0.82–0.98). Although 2007 criteria were found to be associated with prevalent cardiovascular (CV) disease and increased risk of CV death, the 2012 criteria appeared to correspond better with intermediate CV risk markers based on two abstracts. Conclusions: As expected, 2012 hypopnea scoring criteria resulted in a greater prevalence and severity of SDB. Data regarding the effect of varying hypopnea definitions on clinical outcomes, quality of life, health care costs, and mortality rates are limited. Commentary: A commentary on this article appears in this issue on page 683.
AB - Study Objectives: Various criteria have been used for scoring hypopneas, leading to difficulties when comparing results in clinical and research settings. We conducted a systematic review and meta-analysis to assess the effect of different hypopnea definitions on the diagnosis, severity, and clinical implications of sleep-disordered breathing (SDB). Methods: Ovid MEDLINE, Embase, and Scopus databases were queried for English-language publications from inception through March 7, 2017. Studies that directly compared various hypopnea definitions were eligible. The hierarchical summary receiver operating characteristic model was used to jointly estimate diagnostic performance for comparisons between criteria. Results: The initial search yielded 2,828 abstracts; 28 met inclusion criteria. After reviewing reference lists and expert review, five additional articles were identified. Most of the studies were cross-sectional or retrospective in nature. Eleven studies compared 2007 recommended criteria with 2012 criteria; 6 of these (evaluating 6,628 patients) were suitable for inclusion in the meta-analysis. Using the 2012 definition (≥ 3% desaturation or arousal) as the reference standard, the 2007 definition (≥ 4% desaturation) showed a sensitivity of 82.7% (95% confidence interval 0.72–0.90) and specificity of 93.2% (95% confidence interval 0.82–0.98). Although 2007 criteria were found to be associated with prevalent cardiovascular (CV) disease and increased risk of CV death, the 2012 criteria appeared to correspond better with intermediate CV risk markers based on two abstracts. Conclusions: As expected, 2012 hypopnea scoring criteria resulted in a greater prevalence and severity of SDB. Data regarding the effect of varying hypopnea definitions on clinical outcomes, quality of life, health care costs, and mortality rates are limited. Commentary: A commentary on this article appears in this issue on page 683.
KW - Health care costs
KW - Hypopnea
KW - Prevalence
KW - ROC curve
KW - Sensitivity
KW - Sleep apnea syndromes
KW - Specificity
UR - http://www.scopus.com/inward/record.url?scp=85066351640&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85066351640&partnerID=8YFLogxK
U2 - 10.5664/jcsm.7750
DO - 10.5664/jcsm.7750
M3 - Article
C2 - 31053203
AN - SCOPUS:85066351640
SN - 1550-9389
VL - 15
SP - 687
EP - 696
JO - Journal of Clinical Sleep Medicine
JF - Journal of Clinical Sleep Medicine
IS - 5
ER -